L3VLUP
ProSign in

BMRN in the 13F filings

Biomarin Pharmaceutical Inc · CUSIP 09061G101

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 12 Nov 2024
Managers listing it
16
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 12 listed it in both
Shares listed
42,430,164
combined, among listed positions
Reported value
$3.0bn
combined, at the quarter end

Among the 94 comparable managers: 9 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing BMRN in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

16 of 16 holders

ActionFiling
Dodge & Cox13,898,318$977m0.55%Trimmed-32,17513 Nov 2024 (the filing on sec.gov)
Capital Research Global Investors10,494,955$738m0.15%Added+802,38913 Nov 2024 (the filing on sec.gov)
Viking Global Investors LP9,753,293$686m2.50%Added+2,689,72914 Nov 2024 (the filing on sec.gov)
Elliott Investment Management LP3,500,338$246m1.27%Held014 Nov 2024 (the filing on sec.gov)
Balyasny Asset Management LLC910,616$64m0.10%Trimmed-112,87614 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC897,579$63munder 0.1%Trimmed-196,61414 Nov 2024 (the filing on sec.gov)
Man Group PLC616,078$43m0.11%Addedn.a.14 Nov 2024 (the filing on sec.gov)
AQR Capital Management LLC598,500$42m0.06%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Holocene Advisors LP563,476$40m0.16%Trimmed-149,62814 Nov 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP441,200$31m0.13%Added+196,50013 Nov 2024 (the filing on sec.gov)
Two Sigma Investments LP299,531$21munder 0.1%Trimmed-40,91914 Nov 2024 (the filing on sec.gov)
Two Sigma Advisers LP181,314$13munder 0.1%Trimmed-50,60014 Nov 2024 (the filing on sec.gov)
Bridgewater Associates LP142,314$10m0.06%Added+107,33013 Nov 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP78,311$5.5munder 0.1%Newnew12 Nov 2024 (the filing on sec.gov)
PDT Partners LLC33,028$2.3m0.21%Newnew14 Nov 2024 (the filing on sec.gov)
Winton Group Ltd21,313$1.5m0.10%Added+15,12512 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
16 in Q3 2024 to 12 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BMRN by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201314$2.3bnn.a.n.a.
Q3 201314$2.8bnn.a.n.a.
Q4 201311$2.5bnn.a.n.a.
Q1 20148$2.1bnn.a.n.a.
Q2 20149$1.9bnn.a.n.a.
Q3 20148$2.5bnn.a.n.a.
Q4 201412$3.3bnn.a.n.a.
Q1 201515$5.4bnn.a.n.a.
Q2 201514$6.3bnn.a.n.a.
Q3 201520$5.1bnn.a.n.a.
Q4 201514$4.8bnn.a.n.a.
Q1 201610$3.4bnn.a.n.a.
Q2 201611$2.7bnn.a.n.a.
Q3 201617$3.7bnn.a.n.a.
Q4 201613$3.0bnn.a.n.a.
Q1 201711$3.2bnn.a.n.a.
Q2 201714$3.2bnn.a.n.a.
Q3 201716$3.9bnn.a.n.a.
Q4 201716$3.8bnn.a.n.a.
Q1 201817$3.3bnn.a.n.a.
Q2 201814$3.6bnn.a.n.a.
Q3 201814$3.6bnn.a.n.a.
Q4 201813$3.0bnn.a.n.a.
Q1 201915$3.1bnn.a.n.a.
Q2 201919$3.0bnn.a.n.a.
Q3 201913$2.1bnn.a.n.a.
Q4 201915$3.0bnn.a.n.a.
Q1 202014$2.5bnn.a.n.a.
Q2 202011$3.6bnn.a.n.a.
Q3 202012$3.0bnn.a.n.a.
Q4 202012$3.7bnn.a.n.a.
Q1 202110$3.1bnn.a.n.a.
Q2 202111$3.4bnn.a.n.a.
Q3 202114$3.0bnn.a.n.a.
Q4 202114$3.4bnn.a.n.a.
Q1 202219$3.0bnn.a.n.a.
Q2 202221$2.9bnn.a.n.a.
Q3 202225$3.1bnn.a.n.a.
Q4 202226$4.0bnn.a.n.a.
Q1 202320$3.3bnn.a.n.a.
Q2 202318$2.9bnn.a.n.a.
Q3 202318$2.9bnn.a.n.a.
Q4 202322$4.1bn148
Q1 202419$3.6bn164
Q2 202416$3.3bn106
Q3 202416$3.0bn98
Q4 202414$3.0bn112
Q1 202516$3.3bn123
Q2 202516$2.5bn125
Q3 202516$2.3bn105
Q4 202521$2.4bn2419
Q1 202615$2.6bn1426
Q2 202612$2.2bn1322

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BMRN and LLY →BMRN and JNJ →BMRN and VRTX →Choose a stock to compare with BMRN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BMRN, latest filings →Back to the 13F Explorer →